Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 12, 2015, Pages 2079-2085

  Jung, Ji Won ^a,b   Han, Soo Jung ^a   Song, Mi Kyung ^c   Kim, Tae im ^a   Kim, Eung Kweon ^c   Min, Yoo Hong ^c   Cheong, June Won ^c   Seo, Kyoung Yul ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Chronic ocular GVHD severity; Graft versus host disease; Interleukin (IL) 10; Interleukin (IL) 6; Tear cytokines; Tumor necrosis factor (TNF)

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; IL10 PROTEIN, HUMAN; IL17A PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MIDDLE AGED; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; STEM CELL TRANSPLANTATION; AGED; ALLOTRANSPLANTATION; CHEMISTRY; CHRONIC DISEASE; EYE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; LACRIMAL FLUID; METABOLISM; PATHOLOGY; PROSPECTIVE STUDY; SECRETION (PROCESS); SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ADULT; AGED; BIOMARKERS; CHRONIC DISEASE; EYE; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-2; INTERLEUKIN-6; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TEARS; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84947417053     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.08.020     Document Type: Article

References (41)

1. Fraser C.J., Bhatia S., Ness K., et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: A report from the bone marrow transplant survivor study. Blood 2006, 108:2867-2873.
2. Przepiorka D., Anderlini P., Saliba R., et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 2001, 98:1695-1700.
3. Brown R.A., Adkins D., Khoury H., et al. Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality. J Clin Oncol 1999, 17:806-812.
4. Schultz K.R., Paquet J., Bader S., HayGlass K.T. Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease. Bone Marrow Transplant 1995, 16:289-295.
5. Shikari H., Antin J.H., Dana R. Ocular graft-versus-host disease: a review. Surv Ophthalmol 2013, 58:233-251.
6. Brown G.R., Lee E., Thiele D.L. TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice. J Immunol 2002, 168:3065-3071.
7. Couriel D., Caldera H., Champlin R., Komanduri K. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer 2004, 101:1936-1946.
8. Ferrara J.L., Levine J.E., Reddy P., Holler E. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
9. Pidala J., Sarwal M., Roedder S., Lee S.J. Biologic markers of chronic GVHD. Bone Marrow Transplant 2014, 49:324-331.
10. Boehm N., Riechardt A.I., Wiegand M., et al. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest Ophthalmol Vis Sci 2011, 52:7725-7730.
11. von Thun Und Hohenstein-Blaul N., Funke S., Grus F.H. Tears as a source of biomarkers for ocular and systemic diseases. Exp Eye Res 2013, 117:126-137.
12. Li K., Liu X., Chen Z., et al. Quantification of tear proteins and sPLA2-IIa alteration in patients with allergic conjunctivitis. Mol Vis 2010, 16:2084-2091.
13. Grus F.H., Sabuncuo P., Dick H.B., et al. Changes in the tear proteins of diabetic patients. BMC Ophthalmol 2002, 2:4.
14. Bohm D., Keller K., Pieter J., et al. Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach. Oncol Rep 2012, 28:429-438.
15. Matheis N., Okrojek R., Grus F.H., Kahaly G.J. Proteomics of tear fluid in thyroid-associated orbitopathy. Thyroid 2012, 22:1039-1045.
16. Balasubramanian S.A., Pye D.C., Willcox M.D. Levels of lactoferrin, secretory IgA and serum albumin in the tear film of people with keratoconus. Exp Eye Res 2012, 96:132-137.
17. Riemens A., Stoyanova E., Rothova A., Kuiper J. Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation. Mol Vis 2012, 18:797-802.
18. Kang M.H., Kim M.K., Lee H.J., et al. Interleukin-17 in various ocular surface inflammatory diseases. J Korean Med Sci 2011, 26:938-944.
19. Filipovich A.H., Weisdorf D., Pavletic S., et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
20. Ogawa Y., Kim S.K., Dana R., et al. International chronic ocular graft-vs-host-disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (part I). Sci Rep 2013, 3:3419.
21. Bron A.J., Evans V.E., Smith J.A. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003, 22:640-650.
22. Schiffman R.M., Christianson M.D., Jacobsen G., et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000, 118:615-621.
23. Robinson M.R., Lee S.S., Rubin B.I., et al. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant 2004, 33:1031-1035.
24. Lee H., Min K., Kim E.K., Kim T.I. Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe meibomian gland dysfunction. Am J Ophthalmol 2012, 154:949-957.e1.
25. Lee S.Y., Han S.J., Nam S.M., et al. Analysis of tear cytokines and clinical correlations in sjogren syndrome dry eye patients and non-sjogren syndrome dry eye patients. Am J Ophthalmol 2013, 156:247-253.e1.
26. Fujii H., Cuvelier G., She K., et al. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the children's oncology group. Blood 2008, 111:3276-3285.
27. Rozmus J., Schultz K.R., Wynne K., et al. Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: Findings of the children's oncology group study ASCT0031. Biol Blood Marrow Transplant 2011, 17:1804-1813.
28. Dander E., Balduzzi A., Zappa G., et al. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation 2009, 88:1261-1272.
29. Barak V., Levi-Schaffer F., Nisman B., Nagler A. Cytokine dysregulation in chronic graft versus host disease. Leuk Lymphoma 1995, 17:169-173.
30. Tanaka J., Imamura M., Kasai M., et al. Th2 cytokines (IL-4, IL-10 and IL-13) and IL-12 mRNA expression by concanavalin A-stimulated peripheral blood mononuclear cells during chronic graft-versus-host disease. Eur J Haematol 1996, 57:111-113.
31. Weber M., Stein P., Prüfer S., et al. Donor and host B cell-derived IL-10 contributes to suppression of graft-versus-host disease. Eur J Immunol 2014, 44:1857-1865.
32. Tawara I., Sun Y., Liu C., et al. Donor-but not host-derived interleukin-10 contributes to the regulation of experimental graft-versus-host disease. J Leukoc Biol 2012, 91:667-675.
33. Lam H., Bleiden L., de Paiva C.S., et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol 2009, 147:198-205.e1.
34. Yoon K.C., Jeong I.Y., Park Y.G., Yang S.Y. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 2007, 26:431-437.
35. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007, 148:32-46.
36. Serody J.S., Hill G.R. The IL-17 differentiation pathway and its role in transplant outcome. Biol Blood Marrow Transplant 2012, 18(1 Suppl):S56-S61.
37. Tawara I., Koyama M., Liu C., et al. Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation. Clin Cancer Res 2011, 17:77-88.
38. Chen X., Das R., Komorowski R., et al. Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood 2009, 114:891-900.
39. Broady R., Yu J., Chow V., et al. Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells. Blood 2010, 116:5748-5751.
40. Hirano T., Yasukawa K., Harada H., et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986, 324:73-76.
41. Jabs D.A., Wingard J., Green W.R., et al. The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 1989, 107:1343-1348.